Resources

For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Diagnostic Development

Predicting Heart Disease Risk with ‘Good’ Cholesterol: Is it Still Viable?

A new study analysing the cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.
Biomarker Discovery & Development

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Clinical Development

Toxicity Markers of Cognitive Deterioration in Young Cancer Sufferers

Cancer-related cognitive impairment in young adults found pre-treatment, study reports.
Biomarker Discovery & Development

Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Clinical Development

Implementing Patient-Centricity into Biomarker Clinical Trials

How can we better define patient-centric clinical trials within the drug development process?
Clinical Development

Cervical Indicators of HIV Risk Found

Study finds predictive link between genital herpes and HIV.
Diagnostic Development

Predicting Preeclampsia Risk with Placental Proteins

A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.
Clinical Development

Novel Microbial Immunotherapies for Bladder Cancer Treatment

The potential oncolytic applications of Salmonella ZH9 include its use in mitigating diseases such as bladder cancer, with a demonstrated therapeutic effect in cancer models.
Clinical Development

Patient Engagement in Biomarker Development

Christopher Conn, Director of Diagnostics Strategy at Amgen, leads a Discussion Group on patient testing and engagement in biomarker clinical trials.
Biomarker Discovery & Development

Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence

Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?
Clinical Development

Biomarkers for NASH Symposium: Most Anticipated Presentation

Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium 2022.
Clinical Development

Scientists at Stanford Medicine Predict Who Will Develop Vaccine Immunity

A gene signature found in antibody-producing cells could accelerate vaccine development.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery